CELL INTELLIGENCE · 肿瘤细胞治疗研究

从实验台到临床：实体恶性肿瘤 CAR-T 细胞治疗的新兴范式

From Bench to Bedside: Emerging Paradigms in CAR-T Cell Therapy for Solid Malignancies.

可铺展自凝胶止血粉增敏 CAR-NK 细胞治疗以预防肝细胞癌切除后复发

A spreadable self-gelling hemostatic powder sensitizes CAR-NK cell therapy to prevent hepatocellular carcinoma recurrence postresection.

HCC 中基于 NK 细胞的免疫治疗

Natural Killer Cell-Based Immunotherapy in HCC.

NK 细胞在肝脏免疫与耐受中的双重作用：对健康与疾病的意义

The dual roles of natural killer cells in liver immunity and tolerance: Implications for health and disease.

GPC3 嵌合抗原受体 (CAR)-NK 细胞联合 Enoblituzumab 增强抗肝细胞癌疗效

GPC3 chimeric antigen receptor (CAR)-NK cells combined with Enoblituzumab enhance the anti-tumor efficacy against hepatocellular carcinoma.

ROBO1 CAR-NK92 细胞中 Cbl-b 敲除增强其抗肿瘤疗效

Ablation of Cbl-b in ROBO1 CAR-NK92 Cells Enhances Their Antitumor Efficacy.

放疗增强 CAR-NK 细胞对肝细胞癌的抗肿瘤作用

Radiotherapy enhances the anti-tumor effect of CAR-NK cells for hepatocellular carcinoma.

我们的结果表明，在实体瘤模型中，放射能够有效增强 CAR-NK 细胞的抗肿瘤效果。与放疗联合将是一种有吸引力的策略，可提高 CAR-NK 细胞对实体瘤的治疗效果。

可溶性程序性死亡配体-1 对肝细胞癌中靶向 GPC3 的嵌合抗原受体 NK 细胞的免疫抑制效应

Soluble programmed death ligand-1-induced immunosuppressive effects on chimeric antigen receptor-natural killer cells targeting Glypican-3 in hepatoce

靶向 glypican-3 的嵌合抗原受体修饰 NK 细胞的开发及其作为肝细胞癌治疗的优化

Development of glypican-3-specific chimeric antigen receptor-modified natural killer cells and optimization as a therapy for hepatocellular carcinoma.

靶向肝细胞癌的嵌合抗原受体-NK 细胞研究进展

Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma.